期刊文献+

慢性乙型肝炎病毒感染初治人群肾功能异常率及其高危因素回顾

Renal dysfunction in initially treated patients with chronic hepatitis B:Rate and risk factors
下载PDF
导出
摘要 目的:回顾及分析慢性乙型肝炎(chronic viral hepatitis B,CHB)初治人群肾功能异常率及高危因素.方法:收集2013-11/2015-10在蚌埠医学院第一附属医院住院治疗的CHB初治患者.将其分为CHB组、肝硬化代偿期组、肝硬化失代偿期三组,应用简化肾脏病饮食调整工作组方程估算患者的肾小球滤过率值(e-GFR)值,计算该人群中肾功能异常率[e-GFR<90m L/(min·1.73 m^2)],同时对其高危因素行单因素和多因素二分类Logistic回归分析.结果:本研究共收集358例病例,样本总体肾功能异常率:15.9%,其中CHB组:9.5%,肝硬化代偿期:7.9%,肝硬化失代偿期组:25.2%(χ~2=16.726,P=0.000).多因素二分类Logistic回归分析提示年龄、性别、疾病进展、肾结石是肾功能异常的独立危险因素.结论:疾病进展是该特殊人群特有的肾功能异常独立危险因素,临床医生应根据患者具体情况,做出最佳的临床决策. AIM:To investigate the rate of and risk factorsfor renal dysfunction in initially treated patients with chronic hepatitis B.METHODS:Patients with chronic hepatitis B treated at our hospital from November 2013 to October 2015 were divided into a chronic hepatitis B group,a compensated liver cirrhosis group,and a decompensated liver cirrhosis group.The simplified Modification of Diet in Renal Disease Study Equation was used to estimate the glomerular filtration rate(e-GFR) to calculate the rate of renal dysfunction [e-GFR 〈90 m L/(min·1.73 m^2)].The risk factors for renal dysfunction were analyzed by univariate and multivariate binary logistic regression analyses.RESULTS:This study collected a total of 358 cases,of which 15.9% had renal dysfunction.The rate of renal dysfunction was 9.5% for the chronic hepatitis B group,7.9% for the compensated liver cirrhosis group,and 25.2% for the decompensated group(χ~2 = 16.726,P = 0.000).Multivariate binary logistic regression analysis showed that age,sex,disease progression,and kidney stones were independent risk factors for renal dysfunction.CONCLUSION:Disease progression is an independent risk factor for abnormal renal function in initially treated patients with chronic hepatitis B.Clinicians should make the best decision based on the specific condition of the patient.
出处 《世界华人消化杂志》 CAS 2016年第19期3026-3031,共6页 World Chinese Journal of Digestology
关键词 慢乙型肝炎患者 肝硬化 肾小球滤过率 肾功能异常 Chronic hepatitis B Hepatitis cirrhosis Glomerular filtration rate Renal dysfunction
  • 相关文献

参考文献23

  • 1WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva Switzerland: World Health Organization, May 12, 2015.
  • 2贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3212
  • 3Chen YC, Su YC, Li CY, Hung SK. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naYve patients with chronic hepatitis B in Taiwan. BMC Nephrol 2015; 16:110.
  • 4Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009; 5:677-689.
  • 5李小溪,钟春秀,杨淑玲,樊蓉,彭劼,郭亚兵,孙剑,侯金林.阿德福韦酯和替比夫定单药治疗慢性乙型肝炎对肾脏功能影响的比较[J].南方医科大学学报,2012,32(6):826-829. 被引量:42
  • 6Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379:815-822.
  • 7Lee M, Oh S, Lee HJ, Yeum TS, Lee JH, Yu SJ, Kim HY, Yoon JH, Lee HS, Kim YJ. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir- based combination therapy. ] Viral Hepat 2014; 21: 873-881.
  • 8Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters MG, Jacobson IM. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clin Gastroenterol Hepato12015; 13:2071-2087.e16.
  • 9王贵强,王福生,成军,任红,庄辉,孙剑,李兰娟,李杰,孟庆华,赵景民,段钟平,侯金林,贾继东,唐红,盛吉芳,彭劼,鲁凤民,谢青,魏来.慢性乙型肝炎防治指南(2015年版)[J].中华实验和临床感染病杂志(电子版),2015,9(5):1-19. 被引量:519
  • 10韩雪,李菲,宋立文,刘建勇,宓余强.慢性乙型肝炎患者肾功能早期损害的横断面研究[J].天津医药,2015,43(4):375-378. 被引量:10

二级参考文献82

共引文献3786

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部